Limited immunogenicity of HIV CD8+ T-cell epitopes in acute Clade C virus infection

J Infect Dis. 2011 Sep 1;204(5):768-76. doi: 10.1093/infdis/jir394.

Abstract

Background: Human immunodeficiency virus type 1 (HIV-1)-specific CD8(+) responses contribute to the decline in acute peak viremia following infection. However, data on the relative immunogenicity of CD8(+) T-cell epitopes during and after acute viremia are lacking.

Methods: We characterized CD8(+) T-cell responses in 20 acutely infected, antiretroviral-naive individuals with HIV-1 subtype C infection using the interferon-γ enzyme-linked immunosorbent spot assay. Eleven of these had not fully seroconverted at the time of analysis. Viruses from plasma were sequenced within defined cytotoxic T-lymphocyte (CTL) cell epitopes for selected subjects.

Results: At approximately 28 days after estimated initial infection, CD8(+) T-cell responses were directed against an average of 3 of the 410 peptides tested (range, 0-6); 2 individuals had no detectable responses at this time. At 18 weeks, the average number of peptides targeted had increased to 5 (range 0-11). Of the 56 optimal Gag CTL epitopes sequenced, 31 were wild-type in the infecting viruses, but only 11 of 31 elicited measurable CD8(+) T-cell responses.

Conclusions: These data demonstrate that the majority of CD8(+) responses are not elicited during acute HIV infection despite the presence of the cognate epitope in the infecting strain. There is a need to define factors that influence lack of induction of effective immune responses and the parameters that dictate immunodominance in acute infection.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • CD8-Positive T-Lymphocytes / immunology*
  • Enzyme-Linked Immunospot Assay
  • Epitopes, T-Lymphocyte / genetics
  • Epitopes, T-Lymphocyte / immunology*
  • Gene Products, gag / immunology*
  • Gene Products, nef / immunology
  • HIV Infections / immunology*
  • HIV Seropositivity / immunology*
  • HIV-1 / immunology*
  • Humans
  • Interferon-gamma / blood
  • RNA, Viral / blood*
  • Time Factors
  • Viral Load

Substances

  • Epitopes, T-Lymphocyte
  • Gene Products, gag
  • Gene Products, nef
  • RNA, Viral
  • Interferon-gamma